{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:12:50Z","timestamp":1740136370712,"version":"3.37.3"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s10072-023-06874-x","type":"journal-article","created":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T05:01:52Z","timestamp":1685422912000},"page":"3735-3736","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Eyebrow alopecia associated with cladribine treatment for multiple sclerosis"],"prefix":"10.1007","volume":"44","author":[{"given":"Maja Stefanovic","family":"Budimkic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jovana","family":"Ivanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikola","family":"Momcilovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarlota","family":"Mesaros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4516-3458","authenticated-orcid":false,"given":"Jelena","family":"Drulovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,30]]},"reference":[{"key":"6874_CR1","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1177\/1352458510391344","volume":"17","author":"S Cook","year":"2011","unstructured":"Cook S, Vermersch P, Comi G et al (2011) Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study. Mult Scler 17:578\u2013593. https:\/\/doi.org\/10.1177\/1352458510391344","journal-title":"Mult Scler"},{"key":"6874_CR2","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1136\/jnnp-2017-317411","volume":"89","author":"BM Jacobs","year":"2018","unstructured":"Jacobs BM, Ammoscato F, Giovannoni G et al (2018) Cladribine: mechanisms and mysteries in multiple sclerosis. J Neurol Neurosurg Psychiatry 89:1266\u20131271","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"6874_CR3","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162\u2013173. https:\/\/doi.org\/10.1016\/S1474-4422(17)30470-2 Epub 2017 Dec 21","journal-title":"Lancet Neurol"},{"key":"6874_CR4","doi-asserted-by":"publisher","first-page":"117957352211096","DOI":"10.1177\/11795735221109674","volume":"14","author":"MH Porwal","year":"2022","unstructured":"Porwal MH, Salter A, Patel D, Obeidat AZ (2022) Alopecia in multiple sclerosis patients treated with disease modifying therapies. J Cent Nerv Syst Dis 14:11795735221109674. https:\/\/doi.org\/10.1177\/11795735221109674","journal-title":"J Cent Nerv Syst Dis"},{"key":"6874_CR5","doi-asserted-by":"publisher","first-page":"e990","DOI":"10.1212\/NXI.0000000000000990","volume":"8","author":"L Rolfes","year":"2021","unstructured":"Rolfes L, Pfeuffer S, Hackert J et al (2021) Skin reactions in patients with multiple sclerosis receiving cladribine treatment. Neurol Neuroimmunol Neuroinflamm 8:e990","journal-title":"Neurol Neuroimmunol Neuroinflamm"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-06874-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-023-06874-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-06874-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T04:04:38Z","timestamp":1694405078000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-023-06874-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,30]]},"references-count":5,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["6874"],"URL":"https:\/\/doi.org\/10.1007\/s10072-023-06874-x","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2023,5,30]]},"assertion":[{"value":"29 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study is approved by the Institutional Review Board Clinic of Neurology, University Clinical Center of Serbia.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The patient signed informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}